Improved survival with ipilimumab in patients with metastatic melanoma.

RPEP-016272010Hodi, F Stephen; O'Day, Steven J; McDermott, David F; Weber, Robert W; Sosman, Jeffrey A; Haanen, John B; Gonzalez, Rene; Robert, Caroline; Schadendorf, Dirk; Hassel, Jessica C; Akerley, Wallace; van den Eertwegh, Alfons J M; Lutzky, Jose; Lorigan, Paul; Vaubel, Julia M; Linette, Gerald P; Hogg, David; Ottensmeier, Christian H; Lebbé, Celeste; Peschel, Christian; Quirt, Ian; Clark, Joseph I; Wolchok, Jedd D; Weber, Jeffrey S; Tian, Jason; Yellin, Michael J; Nichol, Geoffrey M; Hoos, Axel; Urba, Walter J

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Improved survival with ipilimumab in patients with metastatic melanoma.

The New England journal of medicine, 363(8), 711-23

View on PubMed ↗Publisher’s paper ↗

Citation

Hodi, F Stephen; O'Day, Steven J; McDermott, David F; Weber, Robert W; Sosman, Jeffrey A; Haanen, John B; Gonzalez, Rene; Robert, Caroline; Schadendorf, Dirk; Hassel, Jessica C; Akerley, Wallace; van den Eertwegh, Alfons J M; Lutzky, Jose; Lorigan, Paul; Vaubel, Julia M; Linette, Gerald P; Hogg, David; Ottensmeier, Christian H; Lebbé, Celeste; Peschel, Christian; Quirt, Ian; Clark, Joseph I; Wolchok, Jedd D; Weber, Jeffrey S; Tian, Jason; Yellin, Michael J; Nichol, Geoffrey M; Hoos, Axel; Urba, Walter J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma.. The New England journal of medicine, 363(8), 711-23. https://doi.org/10.1056/NEJMoa1003466